B-CLL
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety of Subcutaneous Alemtuzumab in Patients With B-Cell Chronic Lymphocytic Leukemia (NCT00162851) | Karolinska University Hospital | 2003-04-01 |
Track B-CLL automatically
Every clearance here is in the API, with alerts when new ones post.